#RNase1 activates wild‑type ALK in non‑mutated #NSCLC, driving tumor growth and revealing a novel #oncogenic mechanism, with RDAA‑positive #tumors highly sensitive to FDA‑approved #ALKinhibitors. @mdanderson.bsky.social

#OpenAccess in #STTT: doi.org/10.1038/s413...